Search the Newsreel

Courage Investment Schedules Board Meeting to Approve Interim Results and Consider Dividend

nCino launches Mortgage MCP for AI agent integration

nCino has introduced Mortgage MCP, a new feature for its Mortgage Suite that enables lenders to integrate AI agents directly into their systems using the Model Context Protocol. This aims to streamline mortgage operations by allowing AI agents to perform tasks typically requiring switching …

Courage Investment Signals Sharp Earnings Turnaround on Shipping and Mongolia Expansion

Lipocine Inc (LPCN) Earnings Forecast: Future EPS & Revenue Growth Estimates

Lipocine Inc (LPCN) has an earnings forecast score of 7.00, ranking 306th in the Biotechnology & Medical Research industry. Analysts have set an average price target of $6.88, with a "Buy" rating based on the opinions of 2 analysts. The company's expected revenue for …

Revolution Medicines, Inc. (RVMD) interactive stock chart

Cingulate Inc (CING) Stock News Today

Cintas (CTAS) Splits President And CEO Roles As Jim Rozakis Takes Operations

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Cintas (NasdaqGS: CTAS) has separated the President and CEO roles, with Jim Rozakis appointed President and COO while Todd Schneider remains CEO. The …

Editas Medicine (EDIT) Stock Rallies On Revenue Jump But Losses Linger

Editas Medicine (EDIT) saw its stock rally by about 5% after reporting Q2 2026 earnings, driven by a significant increase in revenue to US$11.89 million from US$3.58 million year-on-year. While the company is still reporting losses, these narrowed to US$18.23 million from US$53.24 million, …

3D Medicines Inc. Announces Director Changes, Effective August 7, 2026

Conestoga Capital Advisors’ Bets on nCino’s (NCNO) Durable Expansion

Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 Index achieving its best first half since 1991 …

Raily Aesthetic Medicine Shifts Hong Kong Principal Office to Tsim Sha Tsui

Raily Aesthetic Medicine Signals Interim Profit on Strong Aesthetic Services and Equipment Sales

Cintas (CTAS) Just Overtook the 20-Day Moving Average

After reaching an important support level, Cintas (CTAS) could be a good stock pick from a technical perspective. CTAS surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend. The 20-day simple moving average is a well-liked trading tool because it provides …

nCino CFO Gregory Orenstein sells $226k in shares

nCino CFO Gregory Orenstein sold 11,780 shares of the company's common stock for approximately $226,388 to cover tax withholding obligations. This transaction was not a discretionary trade. Following the sale, Orenstein still beneficially owns 690,513 shares of nCino, a company which, despite a 26% …

Assenagon Asset Management S.A. Has $207.09 Million Stock Position in Cintas Corporation $CTAS

Assenagon Asset Management S.A. significantly increased its stake in Cintas Corporation, now holding 1.22 million shares valued at $207.09 million. Cintas continues to impress with strong earnings and revenue growth, beating analyst expectations and increasing its quarterly dividend. The company maintains a "Moderate Buy" …

Generate Biomedicines (NasdaqGS:GENB) Stock Forecast & Analyst Predictions

Generate Biomedicines (GENB) is projected to experience a decline in earnings at 10.7% annually, despite an expected 41% annual revenue growth and a 1.6% EPS growth. The company, which is focused on AI-driven drug discovery with a $1.8 billion market cap, faces significant risks …

CTAS|Cintas Corp|Price:203.050|Chg%:+0.900

Cintas Corp (CTAS) has healthy fundamentals and high growth potential, with its valuation considered fairly valued within the Professional & Commercial Services industry. The stock has high institutional ownership and analysts rate it as a "Buy," with expectations for an upward trend in the …

nCino Releases Mortgage MCP for AI Agents | NCNO Stock News

nCino (NASDAQ: NCNO) has introduced Mortgage MCP, a new capability that allows lenders to connect AI agents directly to the nCino Mortgage Suite using the open-source Model Context Protocol (MCP). This solution enables AI agents to perform mortgage tasks on behalf of users, such …

nCino, Inc.: nCino Releases Mortgage MCP, Letting Lenders Connect AI Agents Directly to the nCino Mortgage Suite

nCino, Inc. announced the release of Mortgage MCP, a new capability that allows lenders to directly connect AI agents to the nCino Mortgage Suite using Model Context Protocol (MCP). This innovation aims to streamline mortgage workflows by enabling AI agents to execute tasks through …

nCino Releases Mortgage MCP, Letting Lenders Connect AI Agents Directly to the nCino Mortgage Suite

nCino, Inc. New capability puts the AI agent in the customer's environment while keeping nCino's compliance and permissioning framework intact WILMINGTON, N.C., Aug. 07, 2026 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the platform for agentic AI banking, today announced new capabilities to let …

Press Release: Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update

Generate Biomedicines Inc. has released its financial results for the second quarter of 2026 and provided a business update. This report details the company's financial performance and outlines recent developments and strategic initiatives.

Generate Biomedicines, Inc. Q2 2026: Revenue $6.3M, EPS $(0.52) — 10-Q Summary

Generate Biomedicines, Inc. reported Q2 2026 results with revenue of $6.3M, a 37.7% decline year-over-year, and a net loss of $67.3M, or diluted EPS of $(0.52). The company saw reduced collaboration revenue as partner obligations neared completion but advanced several clinical programs including GB-0895 …

Ncino director Pierre Naude sells $89,882 in stock

Pierre Naude, a director at nCino, Inc. (NASDAQ:NCNO), recently sold 4,677 shares of the company's common stock for $89,882. This transaction, occurring on August 4, 2026, was primarily to cover tax withholding obligations upon the vesting of restricted stock units, not a discretionary trade. …

MediciNova Inc (MNOV) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for MediciNova Inc (MNOV), highlighting its current earnings forecast score, average price target, and analyst ratings. Based on three analysts, the stock has a "Buy" trend with a significant upside space. The report also includes expected revenue and …

Prime Medicine, Inc. 2026: Revenue $11.04M, EPS ($0.24) — 10-Q Summary

Prime Medicine, Inc. (PRME) reported its Q2 2026 financial results, showing revenue of $11.04 million and a net loss of ($42.11M), resulting in a diluted EPS of ($0.24). This represents a decrease in revenue but an improvement in net loss and EPS compared to …

BRIEF-Prime Medicine, Inc. Q2 EPS USD -0.24

Prime Medicine, Inc. reported its Q2 earnings per share (EPS) at USD -0.24. This brief update was sourced from Reuters and made available on TradingView.

Prime Medicine expects 2027 data from two liver gene therapies

Prime Medicine reported its second-quarter 2026 financial results, including a narrowed net loss of $42.1 million and cash reserves of $108.8 million, expected to fund operations into 2027. The company announced significant pipeline progress, with initial clinical data for its two liver gene therapies, …

Courage Investment Group Limited Provides Preliminary Unaudited Consolidated Group Earnings Guidance for the Six Months Ended 30 June 2026

Praxis Precision Medicines (NASDAQ:PRAX) Releases Quarterly Earnings Results, Beats Estimates By $0.80 EPS

nCino's CFO Still Holds $13 Million in Stock After Selling. Here's How to Read It

Gregory Orenstein, the chief financial officer of nCino, Inc. (NASDAQ:NCNO), sold 11,780 shares of common stock on August 4, according to a recent SEC Form 4 filing. Transaction summary Metric Value Transaction value $226,412 Shares sold 11,780 Post-transaction shares (directly held) 690,513 Post-transaction value …

Prime Medicine (NASDAQ:PRME) Announces Earnings Results, Meets Estimates

Prime Medicine (NASDAQ:PRME) announced its earnings results, reporting a quarterly loss of $0.24 per share, which matched analysts' consensus estimates. Despite this, the company continues to face deeply negative profitability metrics, including a net margin of -4,917.55%. Shares traded down to $2.95, near its …

An nCino Insider Sold as Shares Sit 30% Lower. Here's What Long-Term Investors Should Know

Key Points The transaction involved 7,852 shares disposed at a weighted average price of $19.22 per share, totaling about $151,000 on August 4. The disposition represented just 2% of the insider's direct common stock holdings. The sale was a non-discretionary transaction executed to satisfy …

MediciNova (MNOV) Projected to Release Earnings on Thursday

MediciNova (MNOV) is expected to release its Q2 2026 earnings after market close on Thursday, August 13th, with analysts projecting a loss of $0.06 per share and $75,000 in revenue. The company previously reported a loss of $0.05 per share, beating expectations, and matched …

nCino Is Beating Its Guidance, but the Stock Is Down 30%. Here's How to Read a CEO Sale

Key Points The transactions involved the disposition of 40,490 shares at a weighted average price of $19.31 per share, for a total value of $782,000. The activity represented 3% of the insider's direct equity holdings. The disposition was non-discretionary, executed under a Rule 10b5-1 …

Cineverse to Report First Quarter Fiscal 2027 Financial Results on Thursday, August 13, 2026

Cineverse Corp. announced it will release its first quarter fiscal year 2027 financial results after market close on Thursday, August 13, 2026. The company will also host a conference call on the same day at 4:30 p.m. ET to discuss these results, accessible via …

Ncino chief legal & admin ofc. April Rieger sells $150,899 in stock

April Rieger, Chief Legal & Administrative Officer of nCino, sold 7,852 shares of common stock totaling $150,899 to cover tax withholding obligations. This transaction was not a discretionary trade but mandated by the company's equity incentive plans. Despite the sale, nCino shares are down …